Cours Cyteir Therapeutics, Inc.
Actions
CYTT
US23284P1030
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Markus Renschler
CEO | Chief Executive Officer | 63 | 01/05/16 |
David Gaiero
DFI | Director of Finance/CFO | 45 | 01/12/20 |
Susan Doleman
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
John Thero
BRD | Director/Board Member | 63 | 04/02/22 |
Markus Renschler
CEO | Chief Executive Officer | 63 | 01/05/16 |
Jean George
BRD | Director/Board Member | 66 | 01/04/13 |
Varia. 1 janv. | Capi. | |
---|---|---|
-1,42 % | 41,52 Md | |
+42,15 % | 39,9 Md | |
+1,97 % | 38,83 Md | |
-14,19 % | 26,05 Md | |
+1,82 % | 23,78 Md | |
-24,55 % | 18,26 Md | |
-4,07 % | 11,65 Md | |
+21,36 % | 11,53 Md | |
+8,20 % | 11,2 Md |